10.6084/m9.figshare.c.3672760_D2.v1 Tereza Lanitis Tereza Lanitis Robert Leipold Robert Leipold Melissa Hamilton Melissa Hamilton Dale Rublee Dale Rublee Peter Quon Peter Quon Chantelle Browne Chantelle Browne Alexander Cohen Alexander Cohen Additional file 1: of Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences Springer Nature 2017 Venous thromboembolism Apixaban Vitamin K antagonists Cost-effectiveness 2017-01-23 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Cost-effectiveness_of_apixaban_versus_low_molecular_weight_heparin_vitamin_k_antagonist_for_the_treatment_of_venous_thromboembolism_and_the_prevention_of_recurrences/4580434 The objective of this appendix is to provide additional technical documentation to the manuscript detailing the model calculations and data used to calculate the transition matrix in the model. (DOCX 26 kb)